| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 16 |
| 1 | IBUPROFEN | 15 |
| 2 | IBUPFROFEN | 14 |
| 3 | IBUPROFEN 200 MG | 14 |
| 4 | IBUPROFEN 200MG | 14 |
| 5 | IBUPROFEN CAPSULE | 14 |
| 6 | IBUPROFEN CAPSULES 200 MG | 14 |
| 7 | IBUPROFEN ORAL | 14 |
| 8 | IBUPROFEN TABLET, FILM COATED | 14 |
| 9 | IBUPROFEN TABLET, FILM-COATED | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | XYLOMETAZOLINE HYDROCHLORIDE | 6 | 0.0106 |
| 1 | BUTENAFINE HYDROCHLORIDE | 1 | 0.0017 |
| 2 | SODIUM HYALURONATE | 1 | 0.0012 |
| 3 | AMIVANTAMAB-VMJW | 3 | 0.0008 |
| 4 | ERDAFITINIB | 1 | 0.0008 |
| 5 | IBUPROFEN, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 6 | IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0008 |
| 7 | SODIUM CHLORIDE 0.65% | 1 | 0.0007 |
| 8 | EMPAGLIFLOZIN AND LINAGLIPTIN | 1 | 0.0005 |
| 9 | TAPINAROF | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 1 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 2 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 3 | beta3-Adrenergic Agonist [EPC] | 10 | 0.0002 |
| 4 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 22 | 0.0002 |
| 6 | Interleukin-13 Antagonist [EPC] | 1 | 0.0001 |
| 7 | Nonergot Dopamine Agonist [EPC] | 2 | 0.0001 |
| 8 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |